Beulque, Y. et al. 2024. Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab. Acta Oncologica. 63, 1 (Aug. 2024), 658–668. DOI:https://doi.org/10.2340/1651-226X.2024.40390.